Select language:  
1800 620 420
Close menu

AL amyloidosis trials due to open this year offer “new hope”

Two clinical trials will open later this year for newly diagnosed patients with AL amyloidosis with moderate to severe cardiac disease.

  • Amyloidosis
  • Research
  • Treatments and side-effects
Read more
Dr Simon Gibbs at an international haematology conference in Boston, in 2019

Daratumumab – first new myeloma agent PBAC-recommended in years

The drug has received a positive recommendation for PBS listing.

  • Advocacy and policy
  • Myeloma
  • Treatments and side-effects
Read more
Darzalex

Shirley’s “so well” on her latest treatment – daratumumab

Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.

  • Myeloma
  • Treatments and side-effects
Read more
Bruce and Shirley Irwin on the beach

You stepped up for Jack and his family in their darkest hour

Jack was 22 years old when he was diagnosed with a dangerous blood disorder called aplastic anaemia.

  • Other blood cancers
  • Treatments and side-effects
Read more

What’s CAR T-cell therapy?

Dr Bruce Levine explains how it works and why.

  • Research
  • Treatments and side-effects
Read more
Bruce Levine

Cancer-related fatigue – what it is, how it can affect you and how to manage it

Cancer-related fatigue is a side-effect that has an enormous impact on quality of life.

  • Lifestyle and living well
  • Treatments and side-effects
Read more
Andrew Smith - Blood Cancer Support Coordinator

Addressing knowledge gaps in immunoglobulin therapy

Dr Khai Li Chai is working to improve the prevention and treatment of infection in blood cancer patients with antibody replacement therapy.

  • Chronic lymphocytic leukaemia
  • Myeloma
  • Non-Hodgkin lymphoma
  • Research
  • Treatments and side-effects
Read more
Khai Li Chai

Multi-Million Dollar Research Program to fight GVHD

There’s an urgent need for new approaches to better prevent and treat GVHD.

  • Research
  • Treatments and side-effects
Read more
Professor David Gottlieb

Bruce has found his pot of gold – acalabrutinib

Bruce was the first patient in Adelaide to join an international CLL trial.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Bruce Wood and his wife, Belinda Wood

Decisions from the March PBAC meeting for CLL/SLL

Acalabrutinib (Calquence®) will be added to the therapy arsenal for CLL and SLL.

  • Advocacy and policy
  • Chronic lymphocytic leukaemia
  • Other blood cancers
  • Treatments and side-effects
Read more